Otricath

Houston, United States Founded: 2016 • Age: 10 yrs
A closed-loop catheter system is developed for liver cancer treatment.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 11 Brand Intelligence

About Otricath

Otricath is a company based in Houston (United States) founded in 2016. Otricath offers products and services including Otricath Platform and Therapy Delivery Device. Otricath operates in a competitive market with competitors including TriSalus Life Sciences, Cooler Heads, Luminate Medical, Cognos Therapeutics and Delcath, among others.

  • Headquarter Houston, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Nhc, Llc
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Otricath

Otricath offers a comprehensive portfolio of products and services, including Otricath Platform and Therapy Delivery Device.

Product name locked
Category locked
Primary

Delivers cancer-fighting agents to solid tumors with control and safety.

Product name locked
Category locked
Locked

Provides predictable and safe agent delivery for cancer treatment.

Funding Insights of Otricath

Premium access

Detailed funding history for Otricath

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Otricath

Investments
Premium access

Investment portfolio details for Otricath

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Otricath

Premium access

Detailed financials for Otricath

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Otricath Comparisons

Otricath Primary company
Description
A closed-loop catheter system is developed for liver cancer ...
Location
Houston, United States
Founded Year
2016
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Otricath

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Otricath

Otricath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TriSalus Life Sciences, Cooler Heads, Luminate Medical, Cognos Therapeutics and Delcath, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of drug delivery devices to treat cancers
Locked Locked Locked
Developer of cold cap system to prevent chemotherapy side effects
Locked Locked Locked
Developer of a medical device to prevent hair loss during chemotherapy
Locked Locked Locked
Cognos Therapeutics is focused on innovative neurological and oncological treatments.
Locked Locked Locked
Delcath Systems, Inc. is focused on liver cancer treatments.
Locked Locked Locked
Medical device for chemotherapy via reversible electroporation is developed.
Premium access

Detailed competitors of Otricath

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Otricath

Premium access

Complete news archive for Otricath

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Otricath

Otricath was founded in 2016.

Otricath is headquartered in Houston, United States. It is registered at Houston, Texas, United States.

Otricath was founded in 2016 in Houston, United States, within the medical device sector focused on oncology. A closed-loop catheter system is being developed to deliver treatment agents directly to liver tumor sites and extract them post-treatment. This approach is intended to limit agent migration to other body areas, thereby reducing side effects compared to conventional delivery methods. Operations center on advancing this technology for safer cancer interventions.

Otricath's top competitors include TriSalus Life Sciences, Cooler Heads and Cognos Therapeutics.

Otricath offers Otricath Platform and Therapy Delivery Device.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available